Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome: Current Evidence and Controversies in Clinical Practice.
Journal: Clinics in laboratory medicine
Published: October 29, 2025
Recent Advances in Extended Half-Life Products, Nonfactor Replacement Therapies, and Gene Therpy for the Treatment of Hemophilia.
Journal: Clinics in laboratory medicine
Published: October 29, 2025
The dynamic range of immunoassays for heparin-induced thrombocytopenia.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 01, 2024
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.
Journal: JAMA network open
Published: March 26, 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia.
Journal: Blood advances
Published: January 26, 2024
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 28, 2023
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Journal: EClinicalMedicine
Published: July 01, 2022
COVID-19 vaccination associated severe immune thrombocytopenia.
Journal: Experimental hematology & oncology
Published: June 01, 2021
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India.
Journal: Medicine
Published: January 17, 2021
International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 18, 2020
Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors.
Journal: Frontiers in oncology
Published: June 08, 2020
Last Updated: 09/26/2026